Results 101 to 110 of about 418,673 (161)

Systematic review and economic evaluation of a long-acting insulin analogue, insulin glargine

, 2004
Objectives: To evaluate the use of insulin glargine in its licensed basal-bolus indication in terms of both clinical and cost-effectiveness. Data sources: Electronic databases.
Beverley, C., Chilcott, J., Warren, E., Weatherley Jones, E.   +3 more
core  

Evaluation of Early Insulin Glargine Administration in the Treatment of Pediatric Diabetic Ketoacidosis. [PDF]

J Pediatr Pharmacol Ther, 2023
Welter KJ, Marquez JL, Marshik PL, Yao MV, Bickel ES.   +4 more
europepmc   +1 more source

Simplified Switching to Once-Weekly Insulin Icodec Without an Initial One-Time Additional Dose Versus Once-Daily Insulin Glargine U100 in Basal Insulin-Treated Type 2 Diabetes (ONWARDS 10): A Randomised Controlled Trial. [PDF]

Diabetes Obes Metab
Rosenstock J, Mathieu C, Feinberg JB, Rao P, Scavenius C, Cheng AYY.   +5 more
europepmc   +1 more source

Insulin Glargine Biosimilar Prescribing and Cost Trends in the United Kingdom's Primary Care from 2020 to 2024. [PDF]

Pharmacy (Basel)
Alsaif M, Blumer Z.
europepmc   +1 more source

Adverse and Serious Adverse Events Associated With Tocilizumab in COVID-19 Pneumonia and With Cyclosporin, Pazopanib, and Insulin Glargine in Other Diseases: A Single-Center Cross-Sectional Study From a Tertiary Care Center in Bangladesh. [PDF]

Cureus
Ahmed K, Bangash A, Hussain Y, Bangash F, Suny AR, Abdullah ABM.   +5 more
europepmc   +1 more source

Acute episode of erythrodermic psoriasis following self-administration of expired insulin glargine. [PDF]

BMJ Case Rep, 2023
Bevilacqua A, Obua A, Fonarov I, Casadesus D.   +3 more
europepmc   +1 more source

Efficacy and safety of switching basal insulin to insulin glargine 300 U/mL in individuals with inadequately controlled type 2 diabetes on advanced insulin therapies: The Toujeo-Neo T2DM study. [PDF]

Diabetes Obes Metab
Pscherer S, Fritsche A, Anderten H, Pegelow K, Han HY, Pfohl M, Seufert J.   +6 more
europepmc   +1 more source

Real-World Effectiveness of Insulin Glargine 300 U/ml in People with Type 2 Diabetes Previously Treated with Tirzepatide: The DELIVER-T Study. [PDF]

Diabetes Ther
Ritzel R, Davies MJ, Hao L, Ji L, Mk L, Mabunay A, Mauricio D, Bailey T.   +7 more
europepmc   +1 more source

Effects of age and disease duration on the glycaemic outcomes and safety of insulin glargine 300 U/mL in people with type 2 diabetes in China: A post-hoc analysis of the INITIATION study. [PDF]

Diabetes Obes Metab
Chen L, Zhang Q, Duan B, Wu X, Wan H, Wen B, Han J, Liu H, Yang C, Liu W, Du Q, Kang L, Zhang M.   +12 more
europepmc   +1 more source

Comparable glycemic outcomes with insulin glargine and insulin degludec during exercise in adolescents with type 1 diabetes using a standardized management protocol. [PDF]

Diabetes Obes Metab
Rabbone I, Tinti D, Rigamonti A, Mossetto C, Trada M, de Sanctis L, Abate Daga F, Agostino S, Pistone C, Scaramuzza A, Bonfanti R.   +10 more
europepmc   +1 more source